Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:

FDA Role In Non-U.S. Drug Sites To Be Issue At Next Online Pharmacy Hearing

  • News

Executive Summary

Future House hearings on Internet pharmacy sites will likely focus on international sites and federal agencies' roles in controlling them.

You may also be interested in...



PBMs Becoming More Open To Online Pharmacy Participation, Execs Say

Pharmacy benefit management companies' reluctance to allow Internet pharmacies into their prescription provider networks is changing, online pharmacy executives said at a Global Business Research online pharmacy conference in San Francisco Sept. 23.

PBMs Becoming More Open To Online Pharmacy Participation, Execs Say

Pharmacy benefit management companies' reluctance to allow Internet pharmacies into their prescription provider networks is changing, online pharmacy executives said at a Global Business Research online pharmacy conference in San Francisco Sept. 23.

Online Pharmacy Bill Allows FDA To Determine Regulatory Jurisdiction

Rep. Klink's (D-Penn.) "Internet Pharmacy Consumer Protection Act" requires online pharmacies to provide identifying information on their web sites and authorizes FDA to determine which states have "primary enforcement responsibility."
Table

View full table

Related Content

Pink Sheet Pink Sheet
Tags:
UsernamePublicRestriction

Register

PS034916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By